Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth. - Wikidata - wikimedia - TriplyDB

Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth.

Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth.

http://www.wikidata.org/entity/Q36152982

about

A meta-analysis of the relationship between antidepressant use in pregnancy and the risk of preterm birth and low birth weight Pharmacotherapy of obsessive-compulsive disorder during pregnancy: a clinical approach The risks of selective serotonin reuptake inhibitor use in infertile women: a review of the impact on fertility, pregnancy, neonatal health and beyond Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring Methodological considerations in assessing the effectiveness of antidepressant medication continuation during pregnancy using administrative data.Pregnant women screening positive for depressive symptoms at 24-28 weeks may have increased risk of preterm birth but more precise research is needed Can nonrandomized studies on the safety of antidepressants during pregnancy convincingly beat confounding, chance, and prior beliefs?Pregnant women with posttraumatic stress disorder and risk of preterm birth Antidepressant use in pregnant and postpartum women Treatment of nonpsychotic major depression during pregnancy: patient safety and challenges Clinical correlates of prescription opioid analgesic use in pregnancy.Preterm birth and antidepressant medication use during pregnancy: a systematic review and meta-analysis.Prenatal depression and adverse birth outcomes: an updated systematic review.Is the Risk of Preterm Birth and Low Birth Weight Affected by the Use of Antidepressant Agents during Pregnancy? A Population-Based Investigation Are pregnancy planning and timing associated with preterm or small for gestational age births?Placental serotonin: implications for the developmental effects of SSRIs and maternal depression Early Childhood Adversity and Pregnancy Outcomes The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring Selective serotonin reuptake inhibitors and pregnancy: A review of maternal, fetal and neonatal risks and benefits.Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise.Prenatal parental depression and preterm birth: a national cohort study Use of psychotropic medication during pregnancy and the postpartum period.A pharmacological approach to panic disorder during pregnancy.Association of Panic Disorder, Generalized Anxiety Disorder, and Benzodiazepine Treatment During Pregnancy With Risk of Adverse Birth Outcomes.Comparison of Neonatal Abstinence Syndrome Manifestations in Preterm Versus Term Opioid-Exposed Infants.Maternal bereavement and the risk of preterm delivery: the importance of gestational age and of the precursor of preterm birth.The possible effects of depressive symptoms on risk of preterm birth are clouded by lack of control over confounding factors.Are pregnancy planning and pregnancy timing associated with maternal psychiatric illness, psychological distress and support during pregnancy?Impact of antidepressant treatment during pregnancy on obstetric outcomes among women previously treated for depression: an observational cohort study.Is Preconception Substance Use Associated With Unplanned or Poorly Timed Pregnancy?

P2860

Q24623163-C6E16B01-7570-4CF5-9039-C483BB1C9771 Q26774013-A99577EB-497E-4C5B-87D5-10F0398970A6 Q27010327-F2FA0C52-8C14-487D-AB8A-D9BD0887B4E7 Q27027293-745A3B76-2493-41F3-81E2-FCF0AFEF45DD Q30966054-DB2F66A3-878D-47BC-B155-E983F7F419E5 Q33774073-DEBCB9C8-A70C-43E7-BAEF-D150CF00378B Q34049650-E39C8E3E-AA5A-44F3-A026-5A776504B02F Q34053512-7E621FFE-6BA7-4733-BCEE-6645FEBFE26F Q34068023-67C6E057-2DFE-401E-A8F6-558032DA40E9 Q34237681-7C94441B-5756-4BCF-ACDB-566AAE699972 Q34749437-F32F0D61-B6D6-4633-BD89-7F4AD2CF41FD Q35132422-1ED59C2B-B822-4081-8D0C-8F259EA6615F Q35661005-BAF68C17-E2E5-49A5-8F7B-BA31DF5EC8F6 Q36225011-54890701-C1E6-46A2-9ECE-839B04E1B6B5 Q36328422-F4F88E8B-618C-420E-A995-778C558CFFE8 Q36785491-4467479B-8A4A-4A0D-AB91-1240A7835ED0 Q36847873-D840D68E-AC63-41E2-96E6-F369C1FCF661 Q36860205-6D83A6D8-8798-493D-A92C-DCAEA879DE97 Q37216136-0B743B27-5AC8-4094-8C55-ACE68BE62F93 Q37337705-70A4FE75-A57C-419E-BA8E-CB01B5A527A5 Q37394641-1E876C29-921E-49B7-9FF7-18C927791A5A Q38155675-9F95880E-EA3A-4429-B94B-4EBB268EA8A7 Q38516009-1DA99565-6496-451A-BD27-1C1949A381FC Q40043224-8E785FFD-5E74-47B0-9E36-D474925A680C Q40588443-BCD8E920-95B6-4155-8804-57D53E701D65 Q41066433-733B8B99-D531-4FDD-8EFB-D5170EACCDA3 Q45826447-3BDDA575-05D1-4E29-B734-ED5BC93BB69D Q47150901-5EDBEF3A-504E-401D-9E30-8C56DA40D06B Q47835376-63260560-FFEE-4942-A916-40727DE49802 Q52640559-9B7E3F83-D80B-47C7-98D0-BD18078252E5

P2860

Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth.

http://www.wikidata.org/entity/Q36152982

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth.

@ast

Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth.

@en

type

label

Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth.

@ast

Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth.

@en

prefLabel

Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth.

@ast

Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth.

@en

P1433

Q36152982-B8058218-8F83-4C0B-9170-95E71338034D

P1476

Q36152982-92A43B69-2094-478D-A90D-D37577BFD465

P2093

Q36152982-1109708E-463D-419B-86E3-998247A4E3A1

Q36152982-27E33A72-B013-408A-A333-0988068EC060

Q36152982-3E72BCE6-9059-4669-BCAF-62ADA17D2C67

Q36152982-C397FC62-EDB4-4506-A800-55F1B68183C8

Q36152982-D244DB36-1FCF-402E-99E7-03EB4890EA66

Q36152982-DEA447A5-DBCC-400C-8F54-EC721BAEB9BC

Q36152982-E3FAD35B-8D7D-4725-99FD-A88AA601554A

P2860

Q36152982-020D65F7-983F-4FAA-8606-BC1C68DFA8D6

Q36152982-0DC82205-D5F7-4CEE-83EB-116F6B280E16

Q36152982-12176B63-65A0-4F2C-8B3E-EE1BBE5B7B82

Q36152982-1D29E5F8-F670-40EE-AAFC-D05382637477

Q36152982-1E5581A1-43C3-444F-879C-EC1D1E8F4FDF

Q36152982-2090D55D-3659-4B7F-B479-8671C1CE21F4

Q36152982-22CE2F6A-7298-4805-9B68-B2E33CDB3B4F

Q36152982-27AA6A61-EDF9-46C8-A7C3-B8CC7DC51613

Q36152982-2947A6BF-DBC7-4736-9640-663C783DB588

Q36152982-2E0CCED1-ECEC-429C-A05C-D8AAE3139181

P304

Q36152982-FAAE258F-4C35-4502-99EB-8E0231875ADD

P31

Q36152982-1C5441EB-7D0C-4977-B291-E8911E06B675

P356

Q36152982-4FD4634D-5C47-492B-8108-506BCD137B90

P433

Q36152982-476442DF-AB1F-499E-AA74-A17B28609DD8

P478

Q36152982-C0E299BC-7875-45CE-8119-424DA1C886B2

P50

Q36152982-901BCC58-E630-488D-B765-B2BC223EB9D7

P577

Q36152982-F62CEE45-8648-48DA-B1CD-7B2091548C46

P698

Q36152982-24035FEB-E6F0-4405-9A62-13D97FCFFF4E

P932

Q36152982-E63CAC44-83F1-41D7-8DD3-BE0D53D942D9

P356

EDE.0B013E31825838E9

P1433

P1476

Depression and serotonin reuptake inhibitor treatment as risk factors for preterm birth.

@en

P2093

Charles J Lockwood

http://www.w3.org/2001/XMLSchema#string

Edward Luchansky

http://www.w3.org/2001/XMLSchema#string

Errol R Norwitz

http://www.w3.org/2001/XMLSchema#string

Haiqun Lin

http://www.w3.org/2001/XMLSchema#string

Kathleen Belanger

http://www.w3.org/2001/XMLSchema#string

Megan V Smith

http://www.w3.org/2001/XMLSchema#string

Nathan Gotman

http://www.w3.org/2001/XMLSchema#string

P2860

Maternal depressive symptoms, depression, and psychiatric medication use in relation to risk of preterm delivery

Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans

Prenatal depression restricts fetal growth

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.

Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data.

Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy.

Maternal stress and preterm birth.

Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey.

A meta-analysis of depression during pregnancy and the risk of preterm birth, low birth weight, and intrauterine growth restriction

P304

677-685

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/EDE.0B013E31825838E9

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Kimberly Ann Yonkers

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22627901

http://www.w3.org/2001/XMLSchema#string

P932

3415566

http://www.w3.org/2001/XMLSchema#string